Connor, Clark & Lunn Investment Management (CC&L)’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,709
| Closed | -$1.13M | – | 1215 |
|
|
2022
Q3 | $1.13M | Buy |
2,709
+1,099
| +68% | +$458K | 0.01% | 626 |
|
|
2022
Q2 | $797K | Buy |
+1,610
| New | +$797K | ﹤0.01% | 672 |
|
|
2022
Q1 | – | Sell |
-2,562
| Closed | -$1.94M | – | 1038 |
|
|
2021
Q4 | $1.94M | Sell |
2,562
-1,455
| -36% | -$1.1M | 0.01% | 541 |
|
|
2021
Q3 | $3M | Buy |
+4,017
| New | +$3M | 0.02% | 444 |
|
|
2021
Q2 | – | Sell |
-8,637
| Closed | -$4.93M | – | 978 |
|
|
2021
Q1 | $4.93M | Sell |
8,637
-2,734
| -24% | -$1.56M | 0.03% | 358 |
|
|
2020
Q4 | $6.63M | Sell |
11,371
-4,423
| -28% | -$2.58M | 0.04% | 281 |
|
|
2020
Q3 | $8.14M | Buy |
15,794
+3,664
| +30% | +$1.89M | 0.05% | 231 |
|
|
2020
Q2 | $5.48M | Sell |
12,130
-9,620
| -44% | -$4.34M | 0.04% | 278 |
|
|
2020
Q1 | $7.63M | Sell |
21,750
-75
| -0.3% | -$26.3K | 0.07% | 197 |
|
|
2019
Q4 | $8.08M | Buy |
21,825
+11,400
| +109% | +$4.22M | 0.06% | 208 |
|
|
2019
Q3 | $3.47M | Buy |
10,425
+5,475
| +111% | +$1.82M | 0.02% | 318 |
|
|
2019
Q2 | $1.55M | Buy |
+4,950
| New | +$1.55M | 0.01% | 497 |
|